Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference

ConferenceNeutral

AI Analysis

Summary

Cardiol Therapeutics announced its participation in a fireside chat at Canaccord Genuity's 46th Annual Growth Conference. The company is a late-stage life sciences firm developing anti-inflammatory and anti-fibrotic therapies for heart disease.

Importance:2/10

Sentiment:

0.00

conferenceinvestor relationscardiologyanti-inflammatoryanti-fibrotic

Related Companies

$CRDL

Read the original article

Published by PR Newswire Biotech on August 5, 2026 11:27 AM

Read Original